Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-08-014930
Filing Date
2008-11-10
Accepted
2008-11-10 16:36:18
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y72500e10vq.htm 10-Q 376321
2 EX-31.1: CERTIFICATION y72500exv31w1.htm EX-31.1 6359
3 EX-31.2: CERTIFICATION y72500exv31w2.htm EX-31.2 6330
4 EX-32.1: CERTIFICATION y72500exv32w1.htm EX-32.1 3106
5 EX-32.2: CERTIFICATION y72500exv32w2.htm EX-32.2 2947
  Complete submission text file 0000950123-08-014930.txt   396558
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 081176191
SIC: 2835 In Vitro & In Vivo Diagnostic Substances